ExploreNewsPremium
Login
Join this company to show off your team
Surface Oncology logo

Surface Oncology

Surface Oncology is developing next generation immunotherapies that target the immune-suppressive tumor microenvironment to attack cancer.

Org chart

Jeff Goater
CEO
11
Jeff Goater
Jeff Goater
Collapse
Alison O’neill
VP, Clinical Development
0
Alison O’neill
Bob Steininger
SVP CMC
0
Bob Steininger
Jessica Fees
SVP, Finance
0
Jessica Fees
Liisa I. Nogelo
Chief Legal Officer
0
Liisa I. Nogelo
Lisa Mcgrath
VP, Human Resources
0
Lisa Mcgrath
Pamela Holland
VP, Cancer Biology
0
Pamela Holland
Robert Ross
CMO
0
Robert Ross
Shannon Rourke Devens
VP, Clinical Development Operations
0
Shannon Rourke Devens
Stephen Hodi
Scientific Advisor
0
Stephen Hodi
Vito Palombella
CSO
0
Vito Palombella
Wendy Dwyer
Chief Business Officer
0
Wendy Dwyer

Board & Advisors

Alexander Rudensky
Scientific Advisor
Alexander Rudensky
Arlene Sharpe
Scientific Advisor
Arlene Sharpe
Armen Shanafelt
Director
Armen Shanafelt
Carla Rothlin
Scientific Advisor
Carla Rothlin
Christopher Hunter
Scientific Advisor
Christopher Hunter
Daniel Lynch
Chairman
Daniel Lynch
David Grayzel
Director
David Grayzel
David Tuveson
Scientific Advisor
David Tuveson
Elliott Sigal
Scientific Advisor
Elliott Sigal
Geoffrey Mcdonough
Director
Geoffrey Mcdonough
John Stagg
Scientific Advisor
John Stagg
John Wherry
Scientific Advisor
John Wherry
Laurie Stelzer
Director
Laurie Stelzer
Ramy Ibrahim
Director
Ramy Ibrahim
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.